BARCELONA, Spain, Dec. 5, 2019 /PRNewswire/
-- Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ:
GRFS), a leading global producer of plasma-derived medicines and
provider of technologies and services for hospitals, clinics and
compounding centers, today announced the launch of its latest
sterile compounding technology, KIRO Fill®,
as well as its next-generation software enhancements within the
PharmacyKeeper IV workflow platform. The new updates will be
showcased at the Grifols booth, 819, during the ASHP Midyear 2019
Clinical Meeting & Exhibition on December 8-12, 2019, at the Mandalay Bay
Convention Center in Las
Vegas.
KIRO Fill® utilizes automation in
an ISO 5 environment, working in parallel to offer efficient
throughput without sacrificing safety or accuracy during batch
productions of non-hazardous syringe preparations. The solution is
designed to enhance patient safety, optimize operational
efficiencies, and facilitate regulatory compliance.
The newly released PharmacyKeeper software will improve workflow
and safety across the board, including improved visibility into
overall pharmacy operations, the ability to serialize medication
batches, as well as set separate item alternatives for patient and
batch compounds. The enhanced software also features a new module
for storing files, providing a secure, centralized cloud-based
location for managing and storing Standard Operating Procedures and
other documents, and extends bi-directional integration with Epic
to support uncommon or unique drug and dose units with increased
customization.
"KIRO Fill® and PharmacyKeeper are
a strategic part of inclusiv®, our
comprehensive IV compounding portfolio of integrated technology,
software and service solutions," said Michael Glenn, Vice President of Hospital Global
Marketing, Grifols. "They are two of the latest examples of
Grifols' continued investment in innovative solutions for advancing
quality and safety in pharmacy operations."
The inclusiv® portfolio offers expertise
as well as products and services for designing and building
compliant cleanrooms, safely preparing and verifying CSPs
(compounded sterile preparations), and managing and optimizing
hospital pharmacy operations. It includes modular cleanroom
systems, IV workflow systems, robotics and other compounding
devices, and pharmacy operations software.
In addition to the commercial introduction of KIRO
Fill® at the ASHP Midyear 2019
Clinical Meeting & Exhibition, Grifols will exhibit several
other new products and enhancements under the
inclusiv® umbrella, including expanded
capabilities of KIRO Oncology, a robotic system with sophisticated
engineering and software controls that provides accuracy and safety
throughout the highly complex process of compounding hazardous
sterile IV preparations.
For more information on the growing Grifols
inclusiv® compounding portfolio, visit
www.grifolsinclusiv.com.
To learn how you can join Grifols booth 819 at the ASHP Midyear
2019 Clinical Meeting & Exhibition, visit
https://midyear.ashp.org.
About Grifols
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the
health and well-being of people around the world. Its four
divisions – Bioscience, Diagnostic, Hospital and Bio Supplies –
develop, produce and market innovative solutions and services that
are sold in more than 100 countries.
Pioneers in the plasma industry, Grifols operates a growing
network of donation centers worldwide. It transforms collected
plasma into essential medicines to treat rare, chronic and, at
times, life-threatening conditions. As a recognized leader in
transfusion medicine, Grifols also offers a comprehensive portfolio
of solutions designed to enhance safety from donation to
transfusion. In addition, the company supplies tools, information
and services that enable hospitals, pharmacies and healthcare
professionals to efficiently deliver expert medical care.
Grifols, with more than 24,000 employees in 30 countries, is
committed to a sustainable business model that sets the standard
for continuous innovation, quality, safety and ethical
leadership.
The company's class A shares are listed on the Spanish Stock
Exchange, where they are part of the Ibex-35 (MCE: GRF). Grifols
non-voting class B shares are listed on the Mercado Continuo
(MCE: GRF.P) and on the U.S. NASDAQ through ADRs (NASDAQ:
GRFS).
For more information, please visit www.grifols.com
View original
content:http://www.prnewswire.com/news-releases/grifols-streamlines-hospital-pharmacy-operations-with-new-kiro-fill-technology-and-pharmacykeeper-enhancements-300969949.html
SOURCE Grifols